Paul Mahon
Vermögen: 24 Mio $ am 30.06.2026
Vermögen: 24 Mio $ am 30.06.2026
Paul A. Mahon is Co-Managing Director at Unither Therapeutik GmbH.
Mr. Mahon is Secretary, Executive VP & General Counsel at United Therapeutics Corp.
since 2003.
Mr. Mahon is Secretary, Executive VP & General Counsel at Miromatrix Medical, Inc. since 2023.
Mr. Mahon is partner at Hyperion Equity Partners Ltd. Mr. Mahon was Director at SteadyMed Ltd.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.07.2026 | 45 172 ( 0,11 % ) | 24 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | General Counsel | 26.06.1996 |
| MIROMATRIX MEDICAL INC. | General Counsel | 11.12.2023 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| STEADYMED LTD | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miromatrix Medical, Inc.
Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen